Showing 1,121 - 1,135 results of 1,135 for search '"clinical study"', query time: 0.11s Refine Results
  1. 1121
  2. 1122
  3. 1123
  4. 1124

    Tibial stem extension versus standard configuration in primary cemented total knee arthroplasty: systematic review and meta-analysis by Arash Heidari, Mohammad H. Ebrahimzadeh, Mahla Daliri, Ali Moradi, Mahdieh Sahebi, Masoumeh Sadeghi

    Published 2025-01-01
    “…Methods We conducted a comprehensive search of online databases, including Pubmed, Embase, ISI Web of science, Cochrane Library, and Scopus, using the following MeSH terms, (total knee arthroplasty) OR (TKA) OR (total knee replacement) AND (Tibial stem) OR (stem extension) OR (long stem). We included clinical studies that compared the tibial SE with no tibial stem (standard configuration) in primary cemented TKA. …”
    Get full text
    Article
  5. 1125

    The efficacy of platelet-rich plasma in ankle disease: a systematic review and meta-analysis by Qixin Ding, Xu Wang, Yurong Liu, Yuefang Li, Di Zhang, Heling Wang, Shenhong Ma, Qiaohua Han, Weisheng Zhuang

    Published 2024-12-01
    “…Conclusion More clinical studies are needed to further confirm the efficacy of platelet-rich plasma in ankle disorders, and the current study only suggests that platelet-rich plasma may be more effective in talus cartilage injuries than in other types of ankle disorders.…”
    Get full text
    Article
  6. 1126

    Meta-analysis of integrative medicine in the treatment of irradiation cystitis (中西医结合治疗放射性膀胱炎的Meta分析) by SONG Jiangman (宋江曼), LIU Feifei (刘菲菲), LIAN Xiaojing (廉晓静)

    Published 2023-02-01
    “…More high-quality clinical studies are needed for further verification. Totally To comprehensively evaluate the clinical efficacy and advantages of integrated Traditional Chinese and western medicine in the treatment of irradiation cystitis, and provide theoretical guidance for the clinical treatment of irradiation cystitis. …”
    Get full text
    Article
  7. 1127

    Lutetium-177 labeled iPD-L1 as a novel immunomodulator for cancer-targeted radiotherapy by Myrna Luna-Gutiérrez, Erika Azorín-Vega, Rigoberto Oros-Pantoja, Blanca Ocampo-García, Pedro Cruz-Nova, Nallely Jiménez-Mancilla, Gerardo Bravo-Villegas, Clara Santos-Cuevas, Laura Meléndez-Alafort, Guillermina Ferro-Flores

    Published 2025-01-01
    “…Conclusions Therefore, this study warrants further dosimetric and clinical studies to determine the immunomodulatory effect and therapeutic efficacy of 177Lu-iPD-L1 in treating PD-L1-positive tumors in combination with anti-PD-1/PD-L1 immunotherapy protocols.…”
    Get full text
    Article
  8. 1128

    Xixin Decoction’s novel mechanism for alleviating Alzheimer’s disease cognitive dysfunction by modulating amyloid-β transport across the blood–brain barrier to reduce neuroinflamma... by Chaokai Yang, Enlong Zhao, Hu Zhang, Liqi Duan, Xinyue Han, Hongli Ding, Yan Cheng, Dengkun Wang, Dengkun Wang, Dengkun Wang, Xiaojing Lei, Xiaojing Lei, Xiaojing Lei, Yongchang Diwu, Yongchang Diwu, Yongchang Diwu

    Published 2025-01-01
    “…PurposeXixin Decoction (XXD) is a classical formula that has been used to effectively treat dementia for over 300 years. Modern clinical studies have demonstrated its significant therapeutic effects in treating Alzheimer’s disease (AD) without notable adverse reactions. …”
    Get full text
    Article
  9. 1129

    FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy by Liang Zhao, Long Sun, Kaili Fu, Qin Lin, Xiaoyuan Chen, Qicong Luo, Hua Wu, Jianhao Chen, Yangfan Zhou, Yizhen Pang, Guoqiang Su, Haojun Chen

    Published 2025-01-01
    “…Background Fibroblast activation protein (FAP)-targeted radioligand therapy, with immunomodulatory effects, has shown efficacy in both preclinical and clinical studies. We recently reported on a novel dimeric FAP-targeting radiopharmaceutical, 68Ga/177Lu-DOTA-2P(FAPI)2, which demonstrated increased tumor uptake and prolonged retention in various cancers. …”
    Get full text
    Article
  10. 1130

    Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the... by Bruno Fautrel, Yoram Bouhnik, Carine Salliot, Franck Carbonnel, Mathurin Fumery, Christophe Bernardeau, Yves Maugars, Mathurin Flamant, Fabienne Coury, Ben Braithwaite, Salima Hateb, Janet Addison, the PERFUSE investigators

    Published 2024-10-01
    “…Abstract Background There is a need for published data on real-world use of SB5, an adalimumab (ADL) biosimilar approved in Europe in 2017, on the basis of evidence from pre-clinical and analytic data as well as phase I and III clinical studies demonstrating equivalent efficacy and comparable pharmacokinetics, safety and immunogenicity profiles as the reference ADL. …”
    Get full text
    Article
  11. 1131
  12. 1132

    The efficacy and safety of Ginkgo biloba L. leaves extract combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta-analysis of 41 randomized controlled tria... by Zehua Zhang, Shiyun Tang, Shiyu Liu, Yulin Leng, Xiaoxu Fu, Hongyan Xie, Hong Gao, Hong Gao, Chunguang Xie, Chunguang Xie

    Published 2025-01-01
    “…More long-term high-quality clinical studies and in-depth molecular research are still necessary to provide stronger evidence regarding the benefits and safety of GBE in DKD.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/display_record.php?…”
    Get full text
    Article
  13. 1133

    Endocrine disruptors and cancers. [Perturbateurs endocriniens et cancers] by Souhila AOUICHAT BOUGUERRA, Saliha BOUMAZA, Khouloud HEMILA, Samia NEGGAZI, Nadjiba HAMLAT, Sihem BERDJA, Leïla SMAIL, Besma MOHAMMEDI, Kenza REGUOUAT, Amina BOUDJLIDA, Sofiane KACI, Fatima BOUACHRIA-BOUSMAHA

    Published 2024-12-01
    “…These results provide from experimental and clinical studies. By modifying hormonal function, these compounds have potentially patho-logical consequences for the organism exposed to them or for its descendants. …”
    Get full text
    Article
  14. 1134

    A systematic review and meta-analysis of influencing factors of postoperative wound healing in patients with anal fistula (肛瘘患者术后伤口愈合影响因素系统评价与Meta分析)... by CHEN Qi (陈祺), LIU Zhiping (刘志平), BAI Jianying (白建英), LIU Bo (刘博), FENG Jiangxu (冯江雪)

    Published 2024-12-01
    “…Methods The computer searched CNKI, Wanfang, VIP Chinese Database, Pubmeide, Enbas, Weber Benschens and Techco Kranali Liberi English databases to collect clinical studies related to the influencing factors of anal fistula wound healing. …”
    Get full text
    Article
  15. 1135